Using TCGA-HNSCC dataset, Lyn et al. also showed immune-enhancing signatures associated with HRAS mutation, including elevated CD8+ markers and HLA gene expressions, high cytolytic activity, and immune scores86. Here, CD8A is linked to head and neck squamous cell carcinoma.